Innovators in mass spectrometry-based proteomics and bioinformatics, applied to biomarker development and the study of neurodegeneration

Boston
Joined July 2019
Thank you @alzforum for writing such a wonderful article on our recent Cell publication where we mapped distinct post translational modifications for Tau in AD. #alzforum #medicine #alzheimersdisease #tau #dementia #aging #therapeutics #biomarkers alzforum.org/news/research-n…
2
9
We are thrilled that our FLEXIQuant-LF paper has been accepted @eLife. This software maps and quantifies post translationally modified peptides without the use of heavy labelled standards. This expands FLEXIQuant to label-free large-scale proteomics data.elifesciences.org/articles/5…
1
4
3
17
Thank you @ravenscimaven for your music. It’s on repeat in our lab, helping our students understand the immune system like never before!
One of my former students asked me for help with their biology final exam so of course I remixed @theestallion's Body song into #Antibodyody to teach a little about antibodies and the immune response. A quick little song from your favorite scientist #body 😂
2
19
Excited to share our study published in @CellCellPress. In this manuscript we show how the different stages of #Alzheimer's Disease in the human brain are reflected in the chemistry of #Tau protein, which is associated with cognitive decline. authors.elsevier.com/a/1c3w3…
1
1
11
Congratulations to current and previous members of the lab. @BCH, @harvardmed, @FMKirbyNeuro, @RCFNeuro, @ionicwoman
1
4
The Steen lab has just started working on organizing the first 1000 COVID-19 plasma samples here at Boston Children’s Hospital, part of a large NIAID sponsored IMPACC study on SARS-CoV-2. @hipcproject @PrecVaccines @EPICVaccines #COVID19 #BCH
1
6
2
18
More info on this study can be found at niaid.nih.gov/news-events/ni…
1
4
The Steen lab is now on Twitter! Follow us to find out about the lab, current projects, and science at the intersections of bioinformatics, mass spectrometry, high throughput proteomics, biomarker development, and neurodegenerative disorders
14
14